Comparison of Topical and Subconjunctival Curcumin Injection on Corneal Neovascularization on Alkali Injuries of Wistar’s Cornea.
Article Sidebar
-
curcumin, topical, subconjunctival injection, corneal neovascularization
Abstract
Background: Neovascularization of the cornea causing loss of corneal clarity, decrease of visual acuity and also improve the failure of Keratoplasty. It can occur due to the imbalance of angiogenic and antiangiogenic factors such as on chemical trauma. Curcumin is the active extract which have anti-angiogenesis pharmacological effect. Subconjungtival injection have many advantages compared with topical administration. The purpose is to compare the effect of subconjunctival curcumin injection and topical curcumin on corneal neovascularization on alkali injuries of wistar’s cornea.
Methods: Experimental study with post test only control group design using 28 male Wistar rat strain which received chemical trauma. The samples were randomly devided into 4 group. Topical curcumin 80 μmol/L, topical DMSO 0,1% five times daily for 7 days. Subconjunctival injection of curcumin 40 μmol/L and DMSO 0,1% were received once after the chemical trauma on the cornea. On day 8 was measured the corneal neovascularization in length of blood vessels and width of area. Statisticaly hypotheses with independent t-test and significant p < 0,05.
Result: Subconjunctival injection of curcumin group were significantly reduced the area of corneal neovascularization than topical curcumin group (p = 0,045).

Conclusion: Subconjunctival injection of curcumin needs further study to compare the benefits and side effect
Full text article
References
Kim Sub J, et al. The Effect of Curkumin on Corneal Neovascularization in Rabbit Eyes. 2010 (on line): URL: http://web.ebscohost.com/ehost/pdfviewer/pdfviewer?sid=dc6cda8e-775f-42c1-bbe0-53597f67afb8%40sessionmgr114&vid=1&h id=111
Oh Youn J, et al. The Anti-inflammatory Effect of Subconjunctival Bevacizumab on Chemically Burned Rat Corneas. Current Eye Research. 2009.
Yoeruek E, et al. Safety, penetration and efficacy of topically applied bevacizumab: evaluation of eyedrops in corneal neovascularization after chemical burn. 2008 (on line): 
URL: http://onlinelibrary.wiley.com/doi/10.1111/j.1600-0420.2007.01049.x/pdf
Bahar I, et al. Subconjunctival Bevacizumab Injection for Corneal Neovascularization. Cornea. 2008

Bugher, Scrage et all. Chemical Ocular Burn. Springer. 2011; 2: 9
Liesegang TJ, Skuta GL, Cantor LB. External Disease and Cornea. Section 8. San Fransisco: The Foundation of American Academy of Ophthalmology; 2009: 8-12,383-390.
Fuchsluger T.A, et al. Limbal Stem CellDeficiency and Corneal Neovascularization. Seminars in Ophthalmology. 2009
J.L.Arbiser, et al. Kurkumin is an In Vivo Inhibitor of Angiogenesis. (on line): URL. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2230271/
Chandru H, Sharada A.C. Antiangiogenic Effect of Synthetic Analogs of Kurkumin in vivo.(on line): URL. http://www. ajol.info/index.php/ajbr/article/viewFile/50644/39340. 2007
Kenyon et al. A Model of Angiogenesis in the Mouse Cornea. Investigative Ophthalmology and Visual Science.1996
Azar D. Corneal angiogenic privilege : angiogenic and antiangiogenic factors in corneal avascularity, vasculogenesis, and wound healing. Transaction of the American Ophthalmological Society. (on line) : URL. http://www.aosonline.org/xaction/2006/1545-6110_v104_p264.pdf. 2006
Shan Siqing, Dewhirst Mark W. Angiogenesis Assays : A Critical Appraisal of Current Techniques. England. 2006 :171-222
Kenchegowda S, Bazan H. Significant of Lipid Mediators In Corneal Injury and Repair. Journal of Lipid Research. 2009; 51: 879-91
Qazi Y,Madulla S,Ambati B. Mediators of ocular angiogenesis.Utah : Departement of Ophthalmology,Jhon Moran Eye Centre.2009
Ferrara N. Angiogenesis From Basic Science to Clinical Application.New York : CRC PressTaylor & Francis Group;2007 : 1-53
Clauss M,Breiner G.Mechanism of Angiogenesis. Berlin : Springer;2005 :209-300
Kanski JJ. Clinical Ophthalmology. A Systematic Approach. 6th ed. Edinburg: Buttenworth-Heinemann; 2007: 313-16
Kvana A. Ocular Angiogenesis The Role of Growth Factorst. Acta ophthalmologica Scandinavica 2006,84: 282-88
Tink JT, Barnstable CJ. Ocular Angiogenesis : Mechanism and Theurapeutics. New Jersey. Humana Press Inc. 2006 ; 45-66
Jurenka, J. Anti-inflammatory Properties of Kurkumin, a Major Costituent of Curcuma Longa: A Review of Preclinic and Clinical Research. Alternative Medicine Review. 2009; 14: 141-53
W.J. Stanley, H.Robert. Pharmacology of DMSO. Department of Surgery,Oregon Health Science University. (On Line) : URL http://www.dmso.org/articles/information/herschler.htm
Fan Su, Chang Zhang. Inhibitory effect of curcumin on corneal neovascularization in vitro and in vivo. (on line) : URL. http://www.ncbi.nlm.nih.gov/pubmed/18497527
Casser L, Fingaret M, Wodcme HT. Atlas of Primary Eyecare Procedures (On Line) : URL. http://www.iovs.org/ content/37/8/1625.full.pdf+html.1997
Narayan PS. Cheruvu. Transscleral drug delivery. (On Line): URL http://books.google.co.id/books?id=jF_qHAcHJ7oC&pg=PA39&dq=subconjunctival+injection+pathway&hl =id&ei=hq5JTo-zO6jZmAWojcmGCA&sa=X&oi=book_